Showing results (111-120 of 181) with videos related to

Sort By:
Pageof 19
The Lancet. Oncology|June 2, 2009
Resection of the embryologically defined uterovaginal (Müllerian) compartment and pelvic control in patients with cervical cancer: a prospective analysisMichael Höckel, Lars-Christian Horn, Norma Manthey, et al.
Insights Into Imaging|March 23, 2025
Prostate cancer detection with transrectal in-bore MRI biopsies: impact of prostate volume and lesion featuresAlexander Schaudinn, Harald Busse, Constantin Ehrengut, et al.
Pathology Oncology Research : POR|November 24, 2025
Trop2 expression, p16 expression status, and histologic subtype in carcinoma of the uterine cervixGrit Gesine Ruth Hiller, Benjamin Wolf, Mirjam Forberger, et al.
Der Pathologe|July 24, 2020
[Reporting and handling of lymphonodectomy specimens in gynecologic malignancies and sentinel lymph nodes]Anne Kathrin Höhn, Christine E Brambs, Ramona Erber, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|February 8, 2014
Non-invasive estimation of prostate cancer aggressiveness using diffusion-weighted MRI and 3D proton MR spectroscopy at 3.0 TGregor Thörmer, Josephin Otto, Lars-Christian Horn, et al.
Gynecologic Oncology|March 19, 2010
Local spread of cervical cancer revisited: a clinical and pathological pattern analysisMichael Höckel, Thomas Kahn, Jens Einenkel, et al.
Cancer Research|May 22, 2009
Targeting focal adhesion kinase with dominant-negative FRNK or Hsp90 inhibitor 17-DMAG suppresses tumor growth and metastasis of SiHa cervical xenograftsJoerg Schwock, Neesha Dhani, Mary Ping-Jiang Cao, et al.
Pathologie (Heidelberg, Germany)|February 22, 2022
[Revised German guidelines on the diagnosis and treatment of carcinoma of the uterine cervix-what's new for pathologists in 2021?]Lars-Christian Horn, Matthias W Beckmann, Markus Follmann, et al.
Diagnostics (Basel, Switzerland)|August 1, 2018
Quantitative Analysis of Seven New Prostate Cancer Biomarkers and the Potential Future of the 'Biomarker Laboratory'Kevin Cao, Callum Arthurs, Ali Atta-Ul, et al.
Gynecologic Oncology|February 11, 2024
High concordance of molecular subtyping between pre-surgical biopsy and surgical resection specimen (matched-pair analysis) in patients with vulvar squamous cell carcinoma using p16- and p53-immunostainingAnne Kathrin Höhn, Mirjam Forberger, Mona Alfaraidi, et al.
Pageof 19